Cargando…

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schröder, Jens B., Pawlowski, Matthias, Meyer zu Hörste, Gerd, Gross, Catharina C., Wiendl, Heinz, Meuth, Sven G., Ruck, Tobias, Warnecke, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305582/ https://www.ncbi.nlm.nih.gov/pubmed/30619041 http://dx.doi.org/10.3389/fneur.2018.01081

Ejemplares similares

Cerebrospinal Fluid Concentrations of Neuronal Proteins Are Reduced in Primary Angiitis of the Central Nervous System
por: Ruland, Tillmann, et al.
Publicado: (2018)

Substance P Saliva Reduction Predicts Pharyngeal Dysphagia in Parkinson's Disease
por: Schröder, Jens Burchard, et al.
Publicado: (2019)

Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies
por: Heming, Michael, et al.
Publicado: (2019)

Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
por: Schafflick, David, et al.
Publicado: (2020)

High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses
por: Heming, Michael, et al.
Publicado: (2022)

Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses
por: Räuber, Saskia, et al.
Publicado: (2021)

Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry
por: Heming, Michael, et al.
Publicado: (2023)

Bilateral Vocal Fold Paralysis in Myasthenia Gravis: A Case Report and Literature Review
por: Nelke, Christopher, et al.
Publicado: (2020)

Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response
por: Bierhansl, Laura, et al.
Publicado: (2019)

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
por: Straeten, Frederike, et al.
Publicado: (2022)

Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2020)

Cytotoxic CD8(+) T cells and CD138(+) plasma cells prevail in cerebrospinal fluid in non-paraneoplastic cerebellar ataxia with contactin-associated protein-2 antibodies
por: Melzer, Nico, et al.
Publicado: (2012)

Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis
por: Thomas, Christian, et al.
Publicado: (2018)

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
por: Pawlowski, Matthias, et al.
Publicado: (2017)

The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome
por: Nelke, Christopher, et al.
Publicado: (2021)

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
por: Ruck, Tobias, et al.
Publicado: (2015)

Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid
por: Grauer, Oliver M, et al.
Publicado: (2015)

Editorial: Pathophysiologic Insights From Biomarker Studies in Neurological Disorders
por: Bittner, Stefan, et al.
Publicado: (2020)

Immunophenotyping of cerebrospinal fluid cells by Chipcytometry
por: Hümmert, Martin W., et al.
Publicado: (2018)

Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
por: Möhn, Nora, et al.
Publicado: (2019)

Long-term efficacy of alemtuzumab in polymyositis
por: Ruck, Tobias, et al.
Publicado: (2015)

The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis
por: Labeit, Bendix, et al.
Publicado: (2020)

Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory Conditions
por: Gross, Catharina C., et al.
Publicado: (2020)

Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report
por: Müller-Miny, Louisa, et al.
Publicado: (2023)

Novel pathomechanisms in inflammatory neuropathies
por: Schafflick, David, et al.
Publicado: (2017)

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
por: Heming, Michael, et al.
Publicado: (2021)

DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis()
por: Deppe, Michael, et al.
Publicado: (2013)

Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test
por: Warnecke, Tobias, et al.
Publicado: (2021)

Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study
por: Ruck, Tobias, et al.
Publicado: (2019)

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
por: Björkhem, Ingemar, et al.
Publicado: (2018)

Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?
por: Labeit, Bendix, et al.
Publicado: (2019)

Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series
por: Strippel, Christine, et al.
Publicado: (2022)

Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis
por: Kasper, Maren, et al.
Publicado: (2021)

Classification of neurological diseases using multi-dimensional CSF analysis
por: Gross, Catharina C, et al.
Publicado: (2021)

The Agony of Choice? Preserved Affective Decision Making in Early Multiple Sclerosis
por: Landmeyer, Nils C., et al.
Publicado: (2020)

Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
por: Speicher, Anna M., et al.
Publicado: (2019)

Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
por: Ruck, Tobias, et al.
Publicado: (2022)

Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive Neurodegeneration
por: Birkner, Katharina, et al.
Publicado: (2019)

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis—A Longitudinal Observational Study
por: Riepl, Ester, et al.
Publicado: (2018)

Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Rolfes, Leoni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73k7a20gi99lcamrgaa9m2kg2c